Sanofi, TB Alliance collaborate to accelerate new treatments for TB

Monday, September 24, 2012 08:00 AM

Global healthcare company Sanofi and the not-for-profit organization Global Alliance for TB Drug Development (TB Alliance) have formed a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis (TB).

Sanofi and TB Alliance will collaborate to further optimize and develop several novel compounds in Sanofi’s library that have demonstrated activity against Mycobacterium tuberculosis, the bacterium that causes TB. This includes in-depth research of lead compounds based upon identified chemical derivatives of natural products, which have promising potential to treat all forms of TB, and the chemical optimization of other series of compounds that have been identified as “hits” through high-throughput screening.

“By continuing our excellent partnership with the TB Alliance and leveraging our joint resources, we hope to find together new options to fight this dreaded global disease,” said Elias Zerhouni, president of Global R&D, Sanofi.

CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

Date»
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
Region»
- U.S.
- Europe
- Asia
- Emerging Markets
- Global
Company Index
Search

May 20

IRB consolidation trend continues, as private equity firm Audax buys majority stake in Chesapeake

Quintiles, Merck Serono ink exclusive partnership

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

May

INC Research, PPD, inVentiv named top CROs
Yet most CROs slipping in ability to manage site relationships

R&D cuts by sponsors spur more collaboration, innovation
New strategies share pipeline activity costs

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

April

20 innovators changing the face of the clinical trials industry
The CenterWatch Monthly honors individuals, teams and companies for their forward-thinking ideas and their ability to implement them.

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

centerwatch.com/jobwatch

Featured Jobs

More Jobs

About CenterWatch News Online: Developed by CenterWatch, the trusted experts and recognized leaders in clinical research news and analysis, CenterWatch News Online (formerly Clinical Trials Today) is a one-stop, comprehensive resource for clinical research professionals spanning all sectors of the clinical trials industry.

Order Custom PDF Reprints: CenterWatch offers custom PDF reprints of any new or archived article appearing on CenterWatch News Online. This document can be posted on your company's Intranet or web site or used in corporate marketing promotions.To purchase a custom PDF reprint, contact Sales at sales@centerwatch.com or (617) 948-5100.

Contact Us: Editorial | Advertise | View Media Guide

More Resources From CenterWatch

Publications: Newsletters | White Papers | Industry Analysis & Special Reports
Training & Education: Clinical Research Guides | SOPs | Patient Education Resources
Online Services: Research Center and Industry Provider Profiles | Clinical Trials Data Library | Content Licensing | Drugs in Clinial Trials | JobWatch | Clinical Trials | TrialWatch for Sites and Sponsors/CROs